The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data

Sebastian Köhler(Université Toulouse III - Paul Sabatier), Sandra C. Doelken(Charité - Universitätsmedizin Berlin), Chris Mungall(Lawrence Berkeley National Laboratory), Sebastian Bauer(Charité - Universitätsmedizin Berlin), Helen V. Firth(Wellcome Sanger Institute), Isabelle Bailleul‐Forestier(Université Toulouse III - Paul Sabatier), Graeme C. Black(Manchester Academic Health Science Centre), Danielle L. Brown(Centre for Life), Michael Brudno(University of Toronto), Jennifer Campbell(Leeds Teaching Hospitals NHS Trust), David Fitzpatrick(Institute of Genetics and Cancer), Janan T. Eppig(Jackson Laboratory), Andrew P. Jackson(Institute of Genetics and Cancer), Kathleen Freson(Center for Vascular Biology Research), Marta Gîrdea(University of Toronto), Ingo Helbig(University Hospital Schleswig-Holstein), Jane A. Hurst(Great Ormond Street Hospital), Johanna Jähn, Laird G. Jackson(Drexel University), Anne M. Kelly(NHS Blood and Transplant), David H. Ledbetter(Autism & Developmental Medicine Institute), Sahar Mansour(South West London and St George's Mental Health NHS Trust), Christa Lese Martin(Autism & Developmental Medicine Institute), Celia Moss(Birmingham Children's Hospital), Andrew Mumford(University of Bristol), Willem H. Ouwehand(NHS Blood and Transplant), Soo-Mi Park(Addenbrooke's Hospital), Erin Rooney Riggs(Autism & Developmental Medicine Institute), Richard H. Scott(Great Ormond Street Hospital), Sanjay M. Sisodiya(Epilepsy Research UK), Steven Van Vooren(University Colleges Leuven-Limburg), Ronald J. Wapner(Columbia University Irving Medical Center), Andrew O.M. Wilkie(John Radcliffe Hospital), Caroline F. Wright(Wellcome Sanger Institute), Anneke T. Vulto‐van Silfhout(Radboud University Nijmegen), Nicole de Leeuw(Radboud University Nijmegen), Bert B.A. de Vries(Radboud University Nijmegen), Nicole L. Washingthon(Lawrence Berkeley National Laboratory), Cynthia L. Smith(Jackson Laboratory), Monte Westerfield(University of Oregon), Paul N. Schofield(University of Cambridge), Barbara J. Ruef(University of Oregon), Georgios V. Gkoutos(Aberystwyth University), Melissa Haendel(Oregon Health & Science University), Damian Smedley(Wellcome Sanger Institute), Suzanna Lewis(Lawrence Berkeley National Laboratory), Peter N. Robinson
Nucleic Acids Research
November 11, 2013
Cited by 837Open Access
Full Text

Abstract

The Human Phenotype Ontology (HPO) project, available at http://www.human-phenotype-ontology.org, provides a structured, comprehensive and well-defined set of 10,088 classes (terms) describing human phenotypic abnormalities and 13,326 subclass relations between the HPO classes. In addition we have developed logical definitions for 46% of all HPO classes using terms from ontologies for anatomy, cell types, function, embryology, pathology and other domains. This allows interoperability with several resources, especially those containing phenotype information on model organisms such as mouse and zebrafish. Here we describe the updated HPO database, which provides annotations of 7,278 human hereditary syndromes listed in OMIM, Orphanet and DECIPHER to classes of the HPO. Various meta-attributes such as frequency, references and negations are associated with each annotation. Several large-scale projects worldwide utilize the HPO for describing phenotype information in their datasets. We have therefore generated equivalence mappings to other phenotype vocabularies such as LDDB, Orphanet, MedDRA, UMLS and phenoDB, allowing integration of existing datasets and interoperability with multiple biomedical resources. We have created various ways to access the HPO database content using flat files, a MySQL database, and Web-based tools. All data and documentation on the HPO project can be found online.


Related Papers